NCT06465342View on ClinicalTrials.gov

LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)

Not yet recruitingOBSERVATIONAL

Enrollment

80

Participants

Timeline

Start Date

June 12, 2024

Primary Completion Date

September 12, 2025

Study Completion Date

December 12, 2025

Conditions

DML Stage 3

All Listed Sponsors

lead

OFFHEALTH S.p.A.

INDUSTRY

NCT06465342 - LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD) | Biotech Hunter | Biotech Hunter